| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/29/1996 | EP0713914A2 A regulatory gene for the expression of nitrile hydratase gene |
| 05/29/1996 | EP0713707A1 In situ crosslinkable, injectable collagen composition for tissue augmention |
| 05/29/1996 | EP0713532A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 05/29/1996 | EP0713530A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
| 05/29/1996 | EP0713529A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-$g(b) FAMILY |
| 05/29/1996 | EP0713496A1 Fibrin-targeted inhibitors of thrombin |
| 05/29/1996 | EP0713495A1 Methods of enhancing bioactivity of chemokines |
| 05/29/1996 | EP0713493A1 Production of human hemoglobin in transgenic pigs |
| 05/29/1996 | EP0713398A1 POLYPEPTIDES CODED BY EXON v5 OF THE CD44 GENE AS TARGETS FOR IMMUNOTHERAPY AND IMMUNOSCINTIGRAPHY OF TUMOURS |
| 05/29/1996 | EP0713395A1 Polymeric carriers for non-covalent drug conjugation |
| 05/29/1996 | EP0679089A4 Methods for promoting cartilage matrix formation. |
| 05/29/1996 | EP0670737A4 In vivo peptide therapy. |
| 05/29/1996 | EP0650364A4 Purification of factor ix. |
| 05/29/1996 | EP0636171A4 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells. |
| 05/29/1996 | EP0618811A4 Proteolytic mixture containing escharase and method of isolating same. |
| 05/29/1996 | EP0558647B1 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/29/1996 | EP0469065B1 Recombinant antibody-toxin fusion protein |
| 05/29/1996 | EP0431129B1 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 05/29/1996 | EP0415924B1 Regulation of cell proliferation and differentiation using peptides |
| 05/29/1996 | CN1123560A Biological control agents containing mollusc toxins |
| 05/29/1996 | CN1123550A Process for removing endotoxins |
| 05/29/1996 | CN1123325A Process for preparing recombinant aprotinin and recombinant aprotinin variants having the natural N-terminal sequence |
| 05/29/1996 | CN1123185A Immune couplet |
| 05/29/1996 | CN1031893C A mutant of protein for basic fibroblast growth factor, DNA and use thereof |
| 05/29/1996 | CN1031892C Expression of human proapolipoprotein A-I |
| 05/29/1996 | CN1031880C Process for preparing novel analogs of peptidase substrates |
| 05/28/1996 | US5521297 Nucleic acids encoding human metabotropic glutamate receptors |
| 05/28/1996 | US5521296 Glycoprotein and gene coding therefor |
| 05/28/1996 | US5521295 Nucleic acids encoding hybrid receptor molecules |
| 05/28/1996 | US5521288 CD28IG fusion protein |
| 05/28/1996 | US5521287 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| 05/28/1996 | US5521286 Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 05/28/1996 | US5521285 CTAA 28A32, the antigen recognized by MCA 28A32 |
| 05/28/1996 | US5521283 Anti-obesity proteins |
| 05/28/1996 | US5521157 Modified polypeptide compound with VIP-like activity |
| 05/28/1996 | US5521154 Imidoester cross-linked hemoglobin compositions |
| 05/28/1996 | US5521153 Synergistic antifungal protein and compositions containing same |
| 05/28/1996 | US5521093 Genetic engineering process for hirudin |
| 05/28/1996 | US5521086 Secretion sequence for the production of a heterologous protein in yeast |
| 05/28/1996 | US5521084 Bovine heat shock promoter and uses thereof |
| 05/28/1996 | US5521083 Large granular lymphocyte leukemia associated virus |
| 05/28/1996 | US5521078 Genetically engineering cotton plants for altered fiber |
| 05/28/1996 | US5521076 Modified hepatocytes and uses therefor |
| 05/28/1996 | US5521073 Genetic vectors for cell expression |
| 05/28/1996 | US5521072 Vaccines |
| 05/28/1996 | US5521071 Soluble LDL receptor and gene |
| 05/28/1996 | US5521069 Genomic DNA exons having exons encoding human pituitary adenylate cyclase activity peptide with 38 amino acids residues(PACAP38) and a promoter thereof |
| 05/28/1996 | US5521067 Bone marrow cell adhesion molecules and process for detecting adherence between cell adhesion molecules and cells generally |
| 05/28/1996 | US5521066 Periplasmic membrane-bound system for detecting protein-protein interactions |
| 05/28/1996 | US5521063 Polynucleotide reagent containing chiral subunits and methods of use |
| 05/28/1996 | US5520885 Fibrinogen processing apparatus, method and container |
| 05/28/1996 | CA1338349C Method of inducing lysine overproduction in plants |
| 05/23/1996 | WO1996015452A1 METHODS FOR AIDING IN THE DIAGNOSIS OF ALZHEIMER'S DISEASE BY MEASURING AMYLOID-β PEPTIDE (X- ≥41) AND TAU |
| 05/23/1996 | WO1996015272A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 05/23/1996 | WO1996015268A1 Diagnostic method and kit for determining kell blood group genotype |
| 05/23/1996 | WO1996015267A1 Rapid detection and identification of nucleic acid variants and pathogens |
| 05/23/1996 | WO1996015265A1 METHODS FOR MODULATING TRANSCRIPTION FROM THE AMYLOID β-PROTEIN PRECURSOR (APP) PROMOTER |
| 05/23/1996 | WO1996015262A2 Method for the detection of ras oncogenes, in particular the 12-ras oncogene |
| 05/23/1996 | WO1996015249A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 05/23/1996 | WO1996015248A1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 05/23/1996 | WO1996015247A1 Purified papillomavirus proteins |
| 05/23/1996 | WO1996015245A1 A process of inhibiting non-neoplastic pathological cell proliferation |
| 05/23/1996 | WO1996015244A2 Sensory and motor neuron derived factor (smdf) |
| 05/23/1996 | WO1996015243A1 Transcription factor e2f-4 |
| 05/23/1996 | WO1996015242A2 Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor |
| 05/23/1996 | WO1996015241A2 A polynucleotide tuberculosis vaccine |
| 05/23/1996 | WO1996015238A1 Targeted t lymphocytes |
| 05/23/1996 | WO1996015237A2 Delivery system |
| 05/23/1996 | WO1996015232A1 Novel replication process |
| 05/23/1996 | WO1996015231A2 Method for producing biologicals in protein-free culture |
| 05/23/1996 | WO1996015226A1 Regulation of neural stem cell proliferation |
| 05/23/1996 | WO1996015224A1 In vitro induction of dopaminergic cells |
| 05/23/1996 | WO1996015220A1 Process for functional expression of the para cation channel |
| 05/23/1996 | WO1996015151A1 Purification of hemoglobin |
| 05/23/1996 | WO1996015150A1 Process for purifying factor viii |
| 05/23/1996 | WO1996015149A2 Methods and compositions for screening for presynaptic calcium channel blockers |
| 05/23/1996 | WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/23/1996 | WO1996015147A1 Human stanniocalcin-alpha |
| 05/23/1996 | WO1996015146A1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 05/23/1996 | WO1996015145A1 BETA3 INTEGRIN SUBUNIT SPECIFIC POLYPEPTIDES, cDNAs WHICH ENCODE THESE POLYPEPTIDES AND METHODS OF PRODUCING THESE POLYPEPTIDES |
| 05/23/1996 | WO1996015144A2 Chromosome 21 gene marker, compositions and methods using same |
| 05/23/1996 | WO1996015143A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH |
| 05/23/1996 | WO1996015141A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
| 05/23/1996 | WO1996015140A1 Process for purification of factor viii |
| 05/23/1996 | WO1996015139A1 Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out the method |
| 05/23/1996 | WO1996014877A1 Novel tumor suppressor gene, hic-1 |
| 05/23/1996 | WO1996014876A1 Yeast-based delivery vehicles |
| 05/23/1996 | WO1996014866A1 Non-infective vaccines |
| 05/23/1996 | WO1996014860A1 Process for identifying para cation channel modulators |
| 05/23/1996 | WO1996014837A1 Gene therapy for hypercholesterolemia |
| 05/23/1996 | WO1996014836A1 Method and apparatus for gene therapy |
| 05/23/1996 | WO1996014744A1 Protective effects of mutated superantigens |
| 05/23/1996 | WO1996012020A3 Hemoglobin receptors from neisseriae |
| 05/23/1996 | WO1996010580A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 05/23/1996 | WO1996009389A3 Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein |
| 05/23/1996 | WO1996009322A3 Synducin mediated modulation of tissue repair |
| 05/23/1996 | WO1996009066A3 Method of treatment of human immunodeficiency virus (hiv) infection |
| 05/23/1996 | CA2206110A1 Methods and compositions for screening for presynaptic calcium channel blockers |
| 05/23/1996 | CA2205414A1 Novel tumor suppressor gene, hic-1 |
| 05/23/1996 | CA2205392A1 Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out the method |